| Aktie | Ticker | Breite | GCS | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 22.054 $ | +8.217 $ | +36,8 % | 3 | 13.837 $ | +1.218 $ | +17,0 % | 3 | ||||
| Nautilus Biotechnology, Inc. | NAUT | → 0 | Neutral | 11.741 $ | +6.654 $ | +130,8 % | 1 | 5.087 $ | +723 $ | +16,6 % | 1 |
| UiPath, Inc. | PATH | → 0 | Neutral | 9.960 $ | +1.829 $ | +22,5 % | 1 | 8.131 $ | +353 $ | +4,5 % | 1 |
| Ginkgo Bioworks Holdings, Inc. | DNA | → 0 | Schwach | 353 $ | -266 $ | -43,0 % | 1 | 619 $ | +142 $ | +29,8 % | 1 |
| 22.054 $ | +8.217 $ | +36,8 % | 3 | 13.837 $ | +1.218 $ | +17,0 % | 3 | ||||